| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.45 | 7e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |